Spero Therapeutics, Inc. (SPRO)
1.205
+0.06
(+5.70%)
USD |
NASDAQ |
Oct 09, 16:00
1.205
0.00 (0.00%)
After-Hours: 17:35
Spero Therapeutics 30-Day Average Daily Volume : 716918.5 for Oct. 8, 2026
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| October 08, 2026 | 716918.5 |
| October 07, 2026 | 698084.3 |
| October 06, 2026 | 711713.3 |
| October 05, 2026 | 712370.1 |
| October 02, 2026 | 692917.3 |
| October 01, 2026 | 681312.4 |
| September 30, 2026 | 662678.1 |
| September 29, 2026 | 659984.6 |
| September 28, 2026 | 658788.1 |
| September 25, 2026 | 670497.8 |
| September 24, 2026 | 695502.5 |
| September 23, 2026 | 705423.2 |
| September 22, 2026 | 670784.8 |
| September 21, 2026 | 423669.0 |
| September 18, 2026 | 428333.1 |
| September 17, 2026 | 444110.1 |
| September 16, 2026 | 457214.6 |
| September 15, 2026 | 467630.0 |
| September 14, 2026 | 505891.3 |
| September 11, 2026 | 524472.4 |
| September 10, 2026 | 530373.8 |
| September 09, 2026 | 546586.6 |
| September 08, 2026 | 587763.2 |
| September 04, 2026 | 621041.9 |
| September 03, 2026 | 1.001M |
| Date | Value |
|---|---|
| September 02, 2026 | 1.119M |
| September 01, 2026 | 1.180M |
| August 31, 2026 | 1.239M |
| August 28, 2026 | 1.285M |
| August 27, 2026 | 1.317M |
| August 26, 2026 | 1.386M |
| August 25, 2026 | 1.429M |
| August 24, 2026 | 1.784M |
| August 21, 2026 | 1.795M |
| August 20, 2026 | 1.799M |
| August 19, 2026 | 1.793M |
| August 18, 2026 | 1.787M |
| August 17, 2026 | 1.801M |
| August 14, 2026 | 1.803M |
| August 13, 2026 | 1.799M |
| August 12, 2026 | 1.769M |
| August 11, 2026 | 1.758M |
| August 10, 2026 | 1.763M |
| August 07, 2026 | 1.826M |
| August 06, 2026 | 1.848M |
| August 05, 2026 | 1.846M |
| August 04, 2026 | 1.847M |
| August 03, 2026 | 1.898M |
| July 31, 2026 | 2.092M |
| July 30, 2026 | 2.437M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Inovio Pharmaceuticals, Inc. | 2.884M |
| Fortress Biotech, Inc. | 286180.3 |
| Kura Oncology, Inc. | 1.796M |
| ACADIA Pharmaceuticals, Inc. | 2.086M |
| Alnylam Pharmaceuticals, Inc. | 1.503M |